| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3269103 | HPB | 2013 | 6 Pages |
Abstract
R1 resections were associated with a higher risk of intraâhepatic and surgical margin recurrence but did not negatively impact survival suggesting that in the era of efficient chemotherapy, the risk of an R1 resection should not be considered as a contraindication to surgery.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Clarisse Eveno, Mehdi Karoui, Etienne Gayat, Alain Luciani, MarieâLuce Auriault, Michael D. Kluger, Isabelle Baumgaertner, Laurence Baranes, Alexis Laurent, Claude Tayar, Daniel Azoulay, Daniel Cherqui,